Cargando…

Development and Validation of a Prediction Model for 5-Year Risk of Kidney Dysfunction in Patients with Hypertension and Glucose Metabolism Disorder

PURPOSE: Patients with hypertension and glucose metabolism disorder (GMD) are at high risk of developing kidney dysfunction (KD). Therefore, we aimed to develop a nomogram for predicting individuals’ 5-year risk of KD in hypertensives with GMD. PATIENTS AND METHODS: In total, 1961 hypertensives with...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Mengyue, Heizhati, Mulalibieke, Gan, Lin, Yao, Ling, Yang, Wenbo, Li, Mei, Hong, Jing, Wu, Zihao, Wang, Hui, Li, Nanfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880707/
https://www.ncbi.nlm.nih.gov/pubmed/35221736
http://dx.doi.org/10.2147/RMHP.S345059
_version_ 1784659286107881472
author Lin, Mengyue
Heizhati, Mulalibieke
Gan, Lin
Yao, Ling
Yang, Wenbo
Li, Mei
Hong, Jing
Wu, Zihao
Wang, Hui
Li, Nanfang
author_facet Lin, Mengyue
Heizhati, Mulalibieke
Gan, Lin
Yao, Ling
Yang, Wenbo
Li, Mei
Hong, Jing
Wu, Zihao
Wang, Hui
Li, Nanfang
author_sort Lin, Mengyue
collection PubMed
description PURPOSE: Patients with hypertension and glucose metabolism disorder (GMD) are at high risk of developing kidney dysfunction (KD). Therefore, we aimed to develop a nomogram for predicting individuals’ 5-year risk of KD in hypertensives with GMD. PATIENTS AND METHODS: In total, 1961 hypertensives with GMD were consecutively included. Baseline data were extracted from medical electronic system, and follow-up data were obtained using annual health check-ups or hospital readmission. KD was defined as estimated glomerular filtration rate (eGFR) <60 mL/min/1.73m(2). Subjects were randomly divided into training and validation sets with a ratio of 7 to 3. Least absolute shrinkage and selection operator method was used to identify potential predictors. Cox proportional hazard model was applied to build a nomogram for predicting KD risk. The discriminative ability, calibration and usefulness of the model were evaluated. The prediction model was verified by internal validation. RESULTS: During the follow-up of 5351 person-years with a median follow-up of 32 (range: 3–91) months, 130 patients developed KD. Age, sex, ethnicity, hemoglobin A1c, uric acid, and baseline eGFR were identified as significant predictors for incident KD and used for establishing nomogram. The prediction model displayed good discrimination with C-index of 0.770 (95% CI: 0.712–0.828) and 0.763 (95% CI: 0.704–0.823) in training and validation sets, respectively. Calibration curve indicated good agreement between the predicted and actual probabilities. The decision curve analysis demonstrated that the model was clinically useful. CONCLUSION: The prediction nomogram, including six common easy-to-obtain factors, shows good performance for predicting 5-year risk of KD in hypertensives with GMD. This quantitative tool could help clinicians, and even primary care providers, recognize potential KD patients early and make strategy for prevention and management.
format Online
Article
Text
id pubmed-8880707
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-88807072022-02-26 Development and Validation of a Prediction Model for 5-Year Risk of Kidney Dysfunction in Patients with Hypertension and Glucose Metabolism Disorder Lin, Mengyue Heizhati, Mulalibieke Gan, Lin Yao, Ling Yang, Wenbo Li, Mei Hong, Jing Wu, Zihao Wang, Hui Li, Nanfang Risk Manag Healthc Policy Original Research PURPOSE: Patients with hypertension and glucose metabolism disorder (GMD) are at high risk of developing kidney dysfunction (KD). Therefore, we aimed to develop a nomogram for predicting individuals’ 5-year risk of KD in hypertensives with GMD. PATIENTS AND METHODS: In total, 1961 hypertensives with GMD were consecutively included. Baseline data were extracted from medical electronic system, and follow-up data were obtained using annual health check-ups or hospital readmission. KD was defined as estimated glomerular filtration rate (eGFR) <60 mL/min/1.73m(2). Subjects were randomly divided into training and validation sets with a ratio of 7 to 3. Least absolute shrinkage and selection operator method was used to identify potential predictors. Cox proportional hazard model was applied to build a nomogram for predicting KD risk. The discriminative ability, calibration and usefulness of the model were evaluated. The prediction model was verified by internal validation. RESULTS: During the follow-up of 5351 person-years with a median follow-up of 32 (range: 3–91) months, 130 patients developed KD. Age, sex, ethnicity, hemoglobin A1c, uric acid, and baseline eGFR were identified as significant predictors for incident KD and used for establishing nomogram. The prediction model displayed good discrimination with C-index of 0.770 (95% CI: 0.712–0.828) and 0.763 (95% CI: 0.704–0.823) in training and validation sets, respectively. Calibration curve indicated good agreement between the predicted and actual probabilities. The decision curve analysis demonstrated that the model was clinically useful. CONCLUSION: The prediction nomogram, including six common easy-to-obtain factors, shows good performance for predicting 5-year risk of KD in hypertensives with GMD. This quantitative tool could help clinicians, and even primary care providers, recognize potential KD patients early and make strategy for prevention and management. Dove 2022-02-21 /pmc/articles/PMC8880707/ /pubmed/35221736 http://dx.doi.org/10.2147/RMHP.S345059 Text en © 2022 Lin et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Lin, Mengyue
Heizhati, Mulalibieke
Gan, Lin
Yao, Ling
Yang, Wenbo
Li, Mei
Hong, Jing
Wu, Zihao
Wang, Hui
Li, Nanfang
Development and Validation of a Prediction Model for 5-Year Risk of Kidney Dysfunction in Patients with Hypertension and Glucose Metabolism Disorder
title Development and Validation of a Prediction Model for 5-Year Risk of Kidney Dysfunction in Patients with Hypertension and Glucose Metabolism Disorder
title_full Development and Validation of a Prediction Model for 5-Year Risk of Kidney Dysfunction in Patients with Hypertension and Glucose Metabolism Disorder
title_fullStr Development and Validation of a Prediction Model for 5-Year Risk of Kidney Dysfunction in Patients with Hypertension and Glucose Metabolism Disorder
title_full_unstemmed Development and Validation of a Prediction Model for 5-Year Risk of Kidney Dysfunction in Patients with Hypertension and Glucose Metabolism Disorder
title_short Development and Validation of a Prediction Model for 5-Year Risk of Kidney Dysfunction in Patients with Hypertension and Glucose Metabolism Disorder
title_sort development and validation of a prediction model for 5-year risk of kidney dysfunction in patients with hypertension and glucose metabolism disorder
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880707/
https://www.ncbi.nlm.nih.gov/pubmed/35221736
http://dx.doi.org/10.2147/RMHP.S345059
work_keys_str_mv AT linmengyue developmentandvalidationofapredictionmodelfor5yearriskofkidneydysfunctioninpatientswithhypertensionandglucosemetabolismdisorder
AT heizhatimulalibieke developmentandvalidationofapredictionmodelfor5yearriskofkidneydysfunctioninpatientswithhypertensionandglucosemetabolismdisorder
AT ganlin developmentandvalidationofapredictionmodelfor5yearriskofkidneydysfunctioninpatientswithhypertensionandglucosemetabolismdisorder
AT yaoling developmentandvalidationofapredictionmodelfor5yearriskofkidneydysfunctioninpatientswithhypertensionandglucosemetabolismdisorder
AT yangwenbo developmentandvalidationofapredictionmodelfor5yearriskofkidneydysfunctioninpatientswithhypertensionandglucosemetabolismdisorder
AT limei developmentandvalidationofapredictionmodelfor5yearriskofkidneydysfunctioninpatientswithhypertensionandglucosemetabolismdisorder
AT hongjing developmentandvalidationofapredictionmodelfor5yearriskofkidneydysfunctioninpatientswithhypertensionandglucosemetabolismdisorder
AT wuzihao developmentandvalidationofapredictionmodelfor5yearriskofkidneydysfunctioninpatientswithhypertensionandglucosemetabolismdisorder
AT wanghui developmentandvalidationofapredictionmodelfor5yearriskofkidneydysfunctioninpatientswithhypertensionandglucosemetabolismdisorder
AT linanfang developmentandvalidationofapredictionmodelfor5yearriskofkidneydysfunctioninpatientswithhypertensionandglucosemetabolismdisorder